Geode Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51K | Buy |
|
|||||
|
2025
Q1 | $44.8K | Buy |
|
|||||
|
2024
Q4 | $117K | Buy |
|
|||||
|
2024
Q3 | $182K | Buy |
|
|||||
|
2024
Q2 | $341K | Sell |
|
|||||
|
2024
Q1 | $1.29M | Buy |
|
|||||
|
2023
Q4 | $1.33M | Buy |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $2.69M | Buy |
|
|||||
|
2023
Q1 | $7.15M | Buy |
|
|||||
|
2022
Q4 | $8.05M | Buy |
|
|||||
|
2022
Q3 | $4.2M | Buy |
|
|||||
|
2022
Q2 | $4.54M | Buy |
|
|||||
|
2022
Q1 | $6.51M | Buy |
|
|||||
|
2021
Q4 | $6.13M | Buy |
|
|||||
|
2021
Q3 | $9.02M | Buy |
|
|||||
|
2021
Q2 | $8.04M | Buy |
|
|||||
|
2021
Q1 | $10.9M | Buy |
|
|||||
|
2020
Q4 | $10.4M | Buy |
|
|||||
|
2020
Q3 | $8.94M | Buy |
|
|||||
|
2020
Q2 | $8.55M | Buy |
|
|||||
|
2020
Q1 | $3.03M | Buy |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2019
Q3 | $435K | Buy |
|
|||||
|
2019
Q2 | $662K | Buy |
|
|||||
|
2019
Q1 | $250K | Buy |
|